Alternatives to ShapeIn Rx

This record changed completely between checks, and mostly for the better. The founding-member framing that dominated it a week ago is gone: read live on 2026-08-26 KERNX simply says "Semaglutide starts at $129/month and Tirzepatide starts at $229/month. Pricing varies by prescribed dose. No membership fee. No required 3 month plan." What has not gone is the cost outside those figures, and KERNX is unusually straight about it — a provider consultation fee applies when treatment is approved, at $25 for a message-based review, $35 for a standard live visit or $60 for a complex live visit. Two more things this record previously had wrong. It does say where it operates: licensed providers in all 50 states, repeated in its banner and its FAQ. And it publishes a real timeline: a free five-minute assessment, provider review typically within 24 hours, pharmacy processing 1–2 business days and transit 2–3, so most first orders arrive within three to five business days of approval. It also says nothing is charged until a provider approves you.

No video visit and no membership fee — semaglutide from $117.96/mo, tirzepatide from $178.98/mo — but Trava's own pages currently disagree with each other on its clinical-partner name and its cheapest semaglutide price.

Dose-scaling pricing from $189/mo (starting dose) up to $389/mo (top tirzepatide dose), confirmed by pulling the site's own production pricing and states data directly — genuinely specific 48-state coverage (all but AL and MS) and no hidden cancellation fee found in its own Refund Policy.

A named-Medical-Director program licensed in all 50 states, from $99/mo semaglutide and $183/mo tirzepatide, with no membership required — but it carries a 2025 FDA warning letter over how it described its compounded medication, and both prices are 'From' starting prices rather than a guaranteed working-dose rate.

One of the lowest disclosed GLP-1 starting prices in this round — from $99/mo semaglutide, $133/mo tirzepatide — with an explicit no-membership, no-hidden-fee claim, though the real ongoing rate at a working dose isn't confirmed.

A broader wellness platform with GLP-1s starting from $179/mo semaglutide and $255/mo tirzepatide, alongside a longevity catalog — though the 'From' pricing means the real ongoing cost isn't fully confirmed on the public pages.

A multi-category telehealth shop with some of the lowest disclosed GLP-1 starting prices in this batch — from $99/mo semaglutide, $140/mo tirzepatide — though the site's own disclosure that pricing 'may vary' means the real ongoing cost isn't fully locked in.

Now Try Invigor after a domain rebrand from Invigor Medical, pricing two mechanism-based tiers — $225 a month and $350 — via a phone consultation rather than a scheduled video visit, and still never naming the actual molecule on any page. Read live on 2026-08-26, both figures are unchanged since early August. What has changed is what we could find out: its plan pages, which this record had not previously opened, answer the compounded question outright — "Try Invigor does not supply FDA-approved branded medications", everything is compounded by licensed 503A pharmacies, with third-party lot testing including a sterility check published beside it. They also do something almost nothing else on this roster does, which is address pregnancy directly: GLP-1 medications may harm a fetus, should not be used when planning to conceive, and should be stopped at least two months before a planned pregnancy. For a reader on a site like this one, that sentence is worth more than the price.

A granular GLP-1 menu — microdose from $129/mo, semaglutide from $149/mo, tirzepatide from $249/mo, plus an exclusive combined 'GLP-Squared' injection — all stated as all-inclusive, though the site doesn't itemize exactly what that covers.